Abstract
The fact that hepatocellular carcinoma (HCC) has different epidemiological distributions in different parts of the world has facilitated the identification of a series of associated risk factors (Johnson 1996). For instance, a clear association has been shown between HCC and hepatitis B virus (HBV) in areas of the world where HCC has a high incidence (China, Southeast Asia and northern Africa) (Johnson 1996). HCC is also now known to be associated with other risk factors such as hepatitis C virus (HCV), aflatoxins, sex hormones and some metabolic diseases (Johnson 1996; Graham and Alistar 1996). Moreover, there is no doubt that different combinations of risk factors account for the variations in incidence to be found in different geographical areas: for example, exposure to aflatoxin and carriage of hepatitis B surface antigen (HBsAg) are both significant risk factors, but the combination of the two exposes the individual to a much higher risk (Zeman et al. 1985). Furthermore, new diagnostic methods have been developed that allow direct assessment of risk factors. Thus, in recent years it has been possible to detect the HBV surface antigen (HBsAg) and HCC antibodies, and it is now also possible to reveal aflatoxin adducts of DNA in biological fluids as a measure of aflatoxin exposure (Ross et al. 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P (1994) Geographic variation of p53mutational profile in nonmalignant human liver. Science 264:1317–1319
Akagi G, Furuya K, Kanamura A, Chihara T, Otsuka H (1984) Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma. Cancer 54:315–320
Anthony PP (1987) Liver cell dysplasia: what is its significance? Hepatology 7:394–399
Anthony PP, Vogel CL Barker LF (1973) Liver cell dysplasia: premalignant condition. J Clin Pathol 26:217–220
Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. (1986a) Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Gastroenterology 91:198–202
Arakawa M, Kage M, Sugihara S, et al (1986) Small mass lesions in cirrhosis: transition from benign adenomatous hyperplasia to hepatocellular carcinoma. J Gastroenterol Hepatol 1:3–7
Bannasch P (1976) Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules. Cancer Res 36:2555–2559
Bartok I, Remenar E, Toth J, Duschanek P, Kanyar B (1981) Clinicopathological studies of liver cirrhosis and hepatocellular carcinoma in a general hospital. Hum Pathol 12:794–798
Baur M, Hay U, Novaceck G, Dittrich C, Ferrenci P (1992) Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria. Arch Virol 4(5):76–80
Beebe GW,Norman JE (1991) Study of the likelihood of hepatocellular carcinoma following the 1942 US Army epidemic of hepatitis B. In: Tabor E, Di Bisceglie AM, Purcell RH (eds) Etiology, Pathology and Treatment of Hepatocellular carcinoma in North America. Gulf Publishing Company, Houston, pp 3–15
Berti E, D’Errico A, Grigioni WF (1995) Classificazione delle neoplasie primitive epatiche nell’adulto. Il Fegato 1:5–10
Borzio M, Bruno S, Roncalli M,et al (1991) Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report. Br Med J 302:1312–1315
Bruix J, Barrera JM, Calvet X,et al (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006
Buendia MA. (1998) Hepatitis B viruses and cancerogenesis. Biomed and Pharmacother 52:34–43
Bukh J, Miller RH, Kew MC, Purcell RH (1993) Hepatitis C virus RNA in southern Africa blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA 90:1848–1851
Callela F, Fabbretti G, Brisigotti M, et al (1992) Histological diagnosis of hepatocellular carcinoma. Ital J Castroenterol 24:50–55
Caporoso N, Romano N, Marmo R (1991) Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 12:367–372
Caselmann WH, Meyer M, Kekule AS, Lauer U, Hofschneider PH, Koshy R (1990) A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 87:2970–2974
Chen KT and Bocian JJ (1983) Multiple hepatic adenomas. Arch Pathol Lab Med 107:274–276
Chen ML, Gerber MA, Thung SN (1984) Morphometric study of hepatocytes containing hepatitis B surface antigen. Am. J. Pathol. 114:217–222
Choen C, Berson SD (1986) Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients. Cancer 57:1535–1541
Choen C, Berson SD, Geddes EW (1979) Liver cell dysplasia. Association with hepatocellular carcinoma, cirrhosis and hepatitis B antigen carrier status. Cancer 44:1671–1679
Chou WH, Yoneyama T, Takeuchi K, Harada H, Saito J, Miyamura T (1991) Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome. J Clin Microbiol 29:2860–2864
Cohen MB, Beckstead JH, Ferrel LD, Yen B.(1986) Enzyme histochemistry of hepatocellular neoplasms. Am J Surg Pathol 10:789–793
Colombo M, De Franchis R, Del Ninno E, et al (1991) Hepatocellular carcinoma in Italian patients with cirrohosis. N Engl J Med 325:675–680
Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15:225–236
Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Eng J Med 325:675–680
Conte D, Neri A, Fracchiolla NS, Croce LS, Lodi L, Fraquelli M, et al (1994) Analysis of p53 and ras gene mutations in hepatocellular carcinoma in Italy. Eur J Gastroenterol Hepatol 6:1005–1008
Craig, IR, Klatt, EC, Yu M (1991) Role of cirrhosis and the development of HCC: evidence from histologic studies and large population studies. In: Tabor E, Di Bisceglie AM, Purcell RH (eds) Etiology, Pathology, and Treatment of Hepatocellular carcinoma in North America. The Woodlands, New York, pp 103–109
Curry GW, Beattie AD (1996) Pathogenesis of primary hepatocellular carcinoma. Eur J Gastroenterology & Hepatology 8:850–855
Derenzini M, Trere’ D, Olivieri F, et al (1993) Is high AgNOR quantity in hepatocytesassociated with increaed risk of hepatocellular carcinoma in chronic liver dise Ise? J Clin Pathol 36:727–729
Deugnier Y, Guyader D, Crantock L, Lopez J, Turlin B, Yaouanq J et al (1993) Primary liver cancer in genetic heamochromatosis: a clinical, pathological and pathogenetic study in 54 cases. Gastroenterology 104:228–234
Ebara M, Ohto M, Shinagawa T, et al (1986) Natural Histoty of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90:289–296
Edmondson HA (1976) Benign epithelial tumors arid tumorlike lesions of the liver. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York p 309–322
Evarts RP, Nakatsukasa H, Marsden ER, Hsia CC, Ounsford HA, Thorgeirsson SS (1990) Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res 50:3439–3415
Faber E, Sarma DSR (1987) Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest: 56:4–11
Faber E (1976) Hyperplastic areas, hyperplastic nodules and hyperbasophylic areas as putative precursor lesions. Cancer Res 36:2532–2541
Fattovich G, Giustina G, Schalm SW, Hadziyannis S, et al (1995) Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 21:77–82
Fechner RE (1977) Benign hepatic lesions and orally administered contraceptives. Hum Pathol 8:255–261
Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS (1994) Alteration of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 54:281–285
Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H (1988) Macroregenerative nodule of the liver. A clinico-pathologic study of 345 autopsy cases of chronic liver disease. Cancer 61:99–103
Ganjei SH, Nadji M, Albores-Saavedra J, Morales AR (1988) Histologic marker in primary and metastatic tumors of the liver. Cancer 62:1994–1997
Giannini A, Zampi G, Bartoloni F (1987) Morphogical precursors of hepatocellular carcinoma: a morphometrical analysis. Hepatogastroenterology 34:95–103
Gold JH, Guzman IJ, Rosai J (1978) Benign tumors of the liver. Pathologic examination of 45 cases. Am J Clin Pathol 70:6–14
Goopman JD, Cain LG, Kensler TW (1988) Aflatoxin exposure in human populations: measurements and relationship to cancer. CRC Crt Rev Toxicol 19: 113–145
Govindarajan S, Conrad A, Lim B, Valinluck B, Kim AM, Schmid P (1990) Study of preneoplastic changes of liver cells by immunohistochemical and molecular hybridization techniques. Arch Pathol Lab Med 114:1042–1047
Graham WC, Alistar DB (1996) Pathogenesis of primary hepatocellular carcinoma. Eur J Gastroenterol Hepatol 8:850–855
Graig JR, Peters RL, Edmondson HA (1989) Tumoers of the liver and intrahepatic bile ducts. AFIP 26
Grigioni WF, D’Errico A, Bacci F et al (1989) Small liver masses in cirrhotic patient. A pathological clue for the morphogenesis of human hepatocellular carcinoma. Acta Pathol Jpm 39:520–527
Grigioni WF, d’Errico A, Bacci F, Carella R, Mancini AM (1989) Small liver masses in cirrhotic patients. Acta Pathol Jpn 39:520–525
Grigioni WF, D’Errico A, Bacci F, Gaudio M, Mazziotti A, Mancini AM (1989) Primary liver neoplasm; evaluation of proliferative index using MoAb Ki 67. J Pathol 158:28–33
Grigioni WF, d’Errico A, Fortunate C, Cassisa A, Carella R, Mancini AM (1991) The morphogenenesis of human hepatocellular carcinoma. Ital J Gastroenterol 23:594–604
Henmi A, Uchida T, Shikata T (1985) Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer 55:2594–2599
Hirooka N, Nitta Y, Tsunoda T (1990) Microscopic incipient hepatocellular carcinoma found incidentally in a routine liver biopsy specimen. Hepatology 12:291–293
Ho JC, Wu PC, Mak TK (1981) Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong: Int J Cancer 28:571–578
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:1708–1711
Horiuchi R, Uchida T, Koijima T, et al (1990) Inflammatory pseudotumor of the liver: clinicopathological study and rewiew of the literature. Cancer 65:1583–1590
Huang SN, Chisari FV, Strong (1995) Sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 21:620–626
IARC Monogr Eval Carcinog Risks Hum (1993) Aflatoxins 56:245–395
Ishak KG, Sesterhenn IA, Goodman ZD et al (1984) Epitelioid hemangioendothelioma of the liver: a clinicopathological and follow-up study of 32 cases. Hum Pathol 15:839–852
Ishak KG (1988) Benign tumors and pseudotumoers of the liver. Appl Pathol 6:82–104
Johnson PJ (1996) The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 8:845–849
Kagawa K, Deguchi T, Tomimasu H. (1984) Feulgen-DNA cytofluoremetry of the liver cell dysplasia (LCD) in the liver cirrhosis. Gastroenterology 81:82–87
Kan Z, Ivancev K, Lunderquist A, McCuskey PA, McCuskey RS, Wallace S (1995) In vivo microscopy of hepatic metastases: dynamic observation of tumor cell invasion and interaction with Kupffer cells. Hepatology 21:487–494
Kanai T, Hiroashi S, Upton MP, et al (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 60:810–819
Karhunen PJ, Penttila A (187) Preneoplastic lesions of human liver. Hepatogastroenterology 34:10–17
Kekule AS, Lauren U, Meyer M, Caselman VH, Hofschneider PH, Koshy R (1990) A trans-activator function is generated by integration of hepatitisB virus preS/S sequences in human hepatocelluar carcinoma DNA. Proc Nat Acad Sci USA 87: 2970–2974
Kenmochi K, Sugihara S, Koyiro M (1987) Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size and demonstration of tumor cells of multiple different grades in single small HCC. Liver 7:18–23
Kerlin P. Davis GL, McGill DB, Weiland LH, Adson MA and Sheedy PF. (1983) Hepatic adenoma and focal nodular hyperplasia: clinic’, pathologic and radiologic features. Gastroenterology 84:994–1002
Kew MC, Popper H (1984) Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 4: 136–145
Kim CM, Koike R, Saito I, Miyamura I, Jay G, (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
Kirby GM, Chemin I, Montesano R, Chisari FV, Lang, MA, Wild CP (1994) Induction of specific cytochrome p450 s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol Carcinog 11:74–80
Knowles DM, Wolff M (1976) Focal nodular hyperplasia of the liver. A clinicopathologic study and review of the literature. Hum Pathol 7:533–539
Kondo F, Ebara M, Sugiura N (1990) Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 12:592–602
Kondo F, Hirooka N, Wada K, Kondo Y (1987) Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch A 411:15–22
Kondo F, Wada K, Kondo Y (1988) Morphometric analysis of hepatocellular carcinoma. Wirchows Archiv 413:425–431
Kondo F, Wada K, Nagato Y (1989) Biopsy diagnosis of well-differentiates hepatocellular carcinoma based on new morphologic criteria. Hepatology 9:751–758
Kondo Y, Niwa Y, Akikusa B, Takazawa K, Okabayashi A (1983) A histopathologic study of early hepatocellular carcinoma. Cancer 52:687–693
Kuo SH, Sheu JC, Chen DS, Sung JL, Lin CC, Hsu HC (1986) Cytophotometric measurements of nuclear DNA content in hepatocellular carcinomas. Hepatology 7:330–337
Lau JYN, Lai CL (1990) Hepatocarcinogenesis. Trop Gastroenterol. 11:9–24
Ledda-Columbano GM, Coni P, Simbula G, Zedda I, Columbano M (1993) Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect 101:163–168
Lee CC, Liu JY, Lin JK, Chu IS, Shew JY (1998) p53 point mutation enhanced by hepatic regeneration in aflatoxin BI-induced rat liver tumors and preneoplastic lesions. Cancer Letters 125:1–7
Lee RG (1994) Diagnostic liver pathology. Mosby, St. Louis, pp 421–500
Lennert K, Feller AAC (1992) Histopathology of non-Hodgkin’s lymphomas. Springer-Verlag, Berlin
Livni N, Eid A, Ilan Y, et al (1995) p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 75:2420–2426
Lui AF, Hiratzka LF, Hirose FM (1980) Multiple adenomas of the liver. Cancer 45:1001–1009
Mac Sween RNM, Anthony PP, Scheuer PJ (1987) Pathology of the liver. Churchill Livingstone, pp 574–645
Mangia A, Vallari D, Di Bisceglie A.M (1994) Use of confirmatory tests for hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol 43:125–128
Manifold IH, Triger DR, Underwood ICE (1983) Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 2:431–433
Mariani AF, Livingstone AS, Pereiras RV, Van Zuiden PE, Shiff ER (1979) Progressive enlargement of an hepatic cell adenoma. Gastroenterology 77:1319–1323
Matsuno Y, Hirohashi S, Furuya S, Sakamoto M, Mukai K, Shimosato Y (1990) Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma. Jpn J Cancer Res 81:1137–1141
Mc Glynn KA, Rosvold EA, Lusthader ED,et al (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variations in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 14: 2384–2387
Mehta R (1995) The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Letters 93:85–102
Munoz N, Bosch X (1987) Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds) Neoplasm of the liver, Vol I. Springer, Tokio, p 3
Nagasue N, Akamizu H, Yukaya H, Yuuki I (1984) Hepatocellular pseudotumor in the cirrhotic liver. Report of three cases. Cancer 54:2487–2491
Nagato Y, Kondo F, Kondo Y, Ebara M,Ohto M (1991) Histological and morphometrical indicators for a biopsy diagnosis of well-differentiated hepatocellular carcinoma. Hepatology 14:473–477
Nakajima T, Kondo T, Miyazaki M, et al (1988) A histopathological study of 102 cases of intrahepatic cholangiocarcinoma. Histologic classification and modes of spreading. Hum Pathol 19:1228–1234
Nakanuma Y, Ohta G (1985) Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 55:2400–2405
Nakanuma Y and Ohta G (1986) Expression of Mallory bodies in hepatocellular carcinoma in man and its significance. Cancer 57:81–88
Nakanuma Y, Ohta G, Sasaki K (1984) Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa. Arch Pathol Lab Med 108:133–138
Nakanuma Y, Ohta G, Sugiura H, Watanabe K, Doishita K (1986) Incidental solitary hepatocellular carcinomas smaller than 1 cm in size found at autopsy: a morphologic study. Hepatology 6:631–637
Nakanuma Y, Terada T, Terasaki S, et al (1990) Atypical adenomatous hyperplasia in liver cirrhosis: low-grade hepatocellular carcinoma or bordeline lesions? Histopathology 17:27–32
Nakashima T, Okuda K, Kijoro M, Jimi A, Yamaguchi R, Sakamoto K (1983) Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer 51:863–867
Naumov NV, Chokshi S, Metivier E, Maerten G, Johnson PJ, Williams R (1994) HCV replication is an important factor for hepatocellular carcinoma development in patients with cirrhosis. Hepatology 20:285–289
Newberne PM, Butler WH (1969) Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. Cancer Res 29–236–250
Ng IO, Srivastava G, Chung LP, Tsang SW,Ng MM (1994) Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Fong Kong Chinese people. Cancer 74:30–37
Nishioka K, Watanabe J, Furuta S, et a1 (1991) A high prevalòence of antiboby to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67:429–433
Nonomura A, Mizukami Y, Matsubara F, Nakanuma Y (1990) Identification of nucleolar organizer regions in non-neoplastic hepatocytes by the silver-staining technique. Liver 10:229–233
Ogata N, Kamimura T, Asakura H (1991) Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma. Hepatology 13:31–37
Ohno Y, Shiga I Machinami R (1990) A histopathological analysis of five cases of adenomatous hyperplsia containing minute hepatocellular carcinoma. Acta Pathol Jpn 40:267–270
Ohta G, Nakanuma Y (1987)) Comparative study of the three nodular lesions in cirrhosis. Adenomatoid hyperplasia, adenomatoid hyperplasia with intermediate le: ion, and small hepatocellular carcinoma. In: Okuda K, Ishak KG (eds) Neoplasm of the Liver. Springer-Verlag, Berlin, p 177
Oka H, Kurioka N, Kim K, et al (1990) Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12:680–687
Okita K, Kodama T, Haraka T (1977) Early lesions ar d development of primary hepatocellular carcinoma in nan: association with hepatits B viral infection. Gastroenterot Jpn 12:51–55
Okuda K (1986) Early recognition of hepatocellular carcinoma. Hepatology 6:729–738
Okuda K, Ishak KG (1987) Neoplasms of the liver. S:~ringerVerlag, Berlin
Okuda K, Nakashima T, Obata T (1980) Hepatitis B v: rus and primary liver cell carcinoma In: Bianchi L, Gerok W, Sickinger K (eds) Virus and the liver. MTP Press, Lancaster, p 209
Okuda, K, Nakashima T, Sakamoto K (1982) Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers. Cancer 49:450–456
Okuda K, Nakashima T, Koijro M, Kondo Y, Wada K (1989) Hepatocellular carcinoma whithout cirrhosis in J2panese patients. Gastroenterology 97:140–145
Okuno H, Xie ZC, Lu BY, et al (1994) A low prevalence)f anti-hepatitis C virus antibody in patients with hepato~:ellular carcinoma in Guangxi Province, Southern China. Cancer 73:58–62
Omata M, Mori J, Yokosuka O, Iwama S, Ito Y, Okuda K (1982) Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease. Relatioship to liver cell dysplasia. Liver 2:125–130
Ozturk M (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356–1359
Padfield CJH, Ansell ID, Furness PN (1988) Mutinous biliary papillomatosis: a tumour in need of wider recognition. Histopathology 13:687–694
Pascale RM, Simile MM, Feo F (1993) Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy. Anticancer Research 13:1341–1356
Paterlini P, Poussin K, Kew M, Franco D, Brechot C (1995) Selective accumulation of the X trancript of hepatitis B virus in patients negatyive for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313–321
Paterson AC, Kew MC, Duskeiko GM, Isaacson C (1989) Liver cell dysplasia accompanying hepatocellular carcinoma in southern Africa. Differences between urban and rural populations. J Hepatol 8:241–245
Podda M, Roncalli M, Battezzati PM, et al (1992) Liver cell dysplasia and hepatocellular carcinoma. Ital J Gastroenterol 24:39–43
Popper H (1979) Hepatocellular carcinoma: old and new problems. In: Davidson CS (ed) Problems in liver diseases. Georg Thieme, Stuttgart, chap. II
Propst T, Propst A, Dietze O, Judmayer G, Braunsteiner H, Vogel W (1994) Prevalence of hepatocellular carcinoma in alpha-l-antitrypsin deficiency. J Hepatol 21:1006–1011
Reynolds WJ, Wanless IR (1984) Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a morphometric study suggesting a role for hepatic arteritis in the pathogenesis. J Rheumatol 11:838–843
Roncalli M, Borzio M, De Biagi G, et al (1985) Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study. Histopathology 9:209–213
Roncalli M, Borzio M, De Biagi G, et al (1986) Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study. Cancer 57:1515–1519
Roncalli M, Borzio M, Tombesi MV, Ferrari A, Servida E (1988) A morphometric study of liver cell dysplasia. Hum Pathol 19:471–476
Roncalli M, Borzio M, Brando B, Colloredo G, Servida E (1989) Abnormal DNA content in liver cell dysplasia: a flow cytometric study. Int J Cancer 44:204–210
Rooks JB, Org HW, Ishack KG (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644–649
Ross RK, Yuan JM, Yu MC, et al (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943–946
Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multi-step hepatocarcinogenesis: adenomatous hiperplasia and early hepatocellular carcinoma: Hum. Pathol 22:172–176
Salata H, Cortes JM, de Salamanca RE, et al (1985) Porphiria cutanea tarda and hepatocellular carcinoma. I Hepatol 1:477–487
Salisbury JR, Portmann BC (1987) Oncocytic liver cell adenoma. Histopathology 11:533–537
Sano K, Fujioka Y, Nagashima K, et al (1989) Distributional variation of P-450 immunoreactive hepatocytes in human liver disorders. Hum Pathol 20:1015–1019
Schirmacher P, Held WA, Yang D, Biempica L, Rogler CE (1991) Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. Am J Pathol 139:231–237
Seki S, Sakaguchi H, Kawakita N, et al (1990) Identification a fine structure of proliferating hepatocytes in malignant and nonmalignant liver diseases by use of monoclonal antibody against DNA polymerase alpha. Hum Pathol 21:1020–1026
Sell S (1990) Is there a liver stem cell? Cancer Res 50:3811–3817
Sell S, Dunsford HA (1989) Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134:1347–1351
Sell S, Hunt JM, Dunsford HA, Chisari FV (1991) Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 51:1278–1282
Shafritz DA, Kew MC (1981) Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology 1:1–3
Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies end post-mortem tissue specimen. N Ent J Med 305;1067–1073
Sheu JC, Shung JL, Chen DS, et al (1985) Early detection of hepatocellular carcinoma by real-time ultrasonograghy. A prospective study. Cancer 56:660–666
Shinagawa T, Ohto M, Kimura K, et al (1984) Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on utility of real time ultrasonography. A study in 51 patients. Gastroenterology 86:495–499
Simonetti RG, Camma C, Fiorella F, et al (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116:97102
Slagle BL (1995) p53 mutations and hepatitis B virus: cofactors in hepatocellular carcinoma. Hepatology 21:597–599
Sogaard PE (1981) Nodular transfomation of the liver, alphafetoprotein and hepatocellular carcinoma. Hum Pathol 12:1052–1058
Spandau DF, Lee CH (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434
Srivatanakul P, Parkin DM, Khlat M, et al (1991) Liver Cancer in Thailand: II. A case control study of hepatocellular carcinoma. Int J Cancer 48: 329–332
Stal P, Hulcrantz R, Moller L, Eriksson LC (1995) The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology 21:521–528
Steiner PE (1959) Nodular regenerative hyperplasia of liver. Am J Pathol 35:943–946
Sternerg SS, Antonioli DA, Carter D, et al (1994) Diagnostic surgical pathology. Raven Press 2:1517–1580
Stoker JT, Ishak KG (1981) Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer 48:336–339
Strmeyer FW, Ishak KG (1981) Nodular transformation (nodular “regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 12:60–63
Sun D, Kar S, Carr BI (1955) Differentially expressed genesis in TGF-betal sensitive and resistant human hepatoma cells. Cancer Letters 89:73–79
Suwangol P, Jimarkorn P (1980) Liver cell dysplasia in cirrhosis and liver cell carcinoma. J Med Assoc Thailand 63:382–386
Tabarin A, Boulac-Sage P, Boussarie L, Balabaud C, de Mascarel A,Grimaud J.A (1987) Hepatocellular carcinoma developed on non-cirrhotic livers. Sinusoids in hepatocellular carcinoma. Arch Pathol Lab Med 111:174–177
Takayama T, Makuuchi M, Hirohashi S, et al (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150–1157
Tarao K, Shimuzu A, Herada M (1989) Difference in the vitro uptake of bromodeoxiuridine between liver cirrhosis with and without hepatocellular carcinoma. Cancer 64:104–108
Terada T, Nakanuma Y (1989a) Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions. Arch Pathol Lab Med 113:916–919
Terada T, Nakanuma Y (1989b) Survery of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 10:851–856
Terada T, Nakanuma Y (1991) Expression of ABH blood group antigens. Receptors of Ulex Europaeus agglutinin-1, and factor VIII-related antigen on sinusoidal endothelial cells in adenomatous hyperplasia in human cirrhotic livers. Hum Pathol 22:486–489
Terada T, Hoso M, Nakanuma Y (1989a) Mallory body clustering in adenomatous hyperplasia in human cirrhotic livers: report of four cass. Hum Pathol 20:886–889
Terada T, Nakanuma Y, Hoso M, Saito K, Sasaki M, Nonmura A. (1989b) Fatty macroregenerative nodule in nonsteatotic liver cirrhosis. Virchows Arch. 415:131–134
Terada T, Kadoya M, Nakanuma Y, Matsui 0 (1990) Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 65:1994–1999
Terasaki S, Terada T, Nakanuma Y, Nonomura A, Unoura M, Kobayashi K. (1991) Argyrophilic nucleolar organizer regions and alpha-fetoprotein in adenomatous hyperplasia in human cirrhotic livers. Am J Clin Pathol 95:850–854
Toshkov I, Chisari VF, Bannasch P (1994) Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology 20:1162–1172
Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H (1988) Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 95:1664–1667
Twu JS, Schloemer R.H (1987) Transcriptional trans-activat- ing function of hepatitis B virus. J Virol 61:3443–3453
Uchida T, Miyata H, Shikata T (1981) Human hepatocellular carcinoma and putatyive precancerous disocers. Arch Pathol Lab Med 105:180–183
Vecchio FM, Fabiano A, Manna R, Massi G (1984) Fibrolamellar carcinoma of the liver: the malignant counterpart of focale nodular hyperplasia with:)ncocytic change. Am J Clin Pathol 81:521–524
Wada K, Kondo F, Kondo Y (1988) Large regenerative nodules and dysplastic nodules in cirrhotic livers: a hi~topathologic study. Hepatology 8:1684–1686
Wands JR, Blum HE (1991) Primary hepatocellular carcinoma. N Engl J Med 325:729–731
Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification o’’ hepatocellular nodules. Hepatology 11:787–797
Watanabe S, Okita K, Harada T, et al (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:219–2199
Yaiginuma H, Kobayashi H, Kobayashi M, et al (1987) Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children. J Virol 61:1808–1813
Zeman SN, Melia WM, Johnson RD, Johnson PJ, Williams R (1985) Risk factors for the development of hepatocellular carcinoma in cirrhosis. A prospective study of 613 patients. Lancet 1:1357–1360
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vaccari, M., Lattes, C., Grigioni, W.F. (1999). Carcinogenesis and Pathological Classification of Hepatocellular Carcinoma. In: Bartolozzi, C., Lencioni, R. (eds) Liver Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58641-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-58641-5_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63679-0
Online ISBN: 978-3-642-58641-5
eBook Packages: Springer Book Archive